Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Sight Sciences ( (SGHT) ) just unveiled an update.
On January 24, 2025, Sight Sciences’ Compensation Committee approved increases in annual base salaries and target cash incentive bonuses for key executive officers for Fiscal 2025. The company’s cash incentive program for 2025 will be based on achieving specific milestones related to revenue, operating expenses, and market and product development goals, impacting the company’s strategic focus and operational benchmarks.
More about Sight Sciences
Sight Sciences, Inc. operates in the medical device industry, focusing on developing and commercializing technology-driven solutions to address prevalent eye diseases.
YTD Price Performance: -18.44%
Average Trading Volume: 254,000
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $148.7M
See more insights into SGHT stock on TipRanks’ Stock Analysis page.